Key Details
Price
$13.51Last Dividend
$0.15Annual Revenue
$31.59 BAnnual EPS
$1.34Annual ROE
7.46%Beta
0.90Events Calendar
Next earnings date:
Feb 13, 2025Recent quarterly earnings:
Oct 24, 2024Recent annual earnings:
Feb 20, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
Aug 16, 2024Next split:
N/ARecent split:
Feb 19, 2014Analyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
Barclays performed exceptionally well in 2024, increasing by more than 70% due to a recovery in investment banking, effective cost management, and improved net interest margins despite lower rates. The company's management has set ambitious income growth targets until FY26, which the market has not yet fully considered, along with plans for significant returns to shareholders. Unlike other UK banks, Barclays is in a strong position to take advantage of both rising and falling rates because of its structural hedges and investment banking division, providing several opportunities for growth.
According to two sources familiar with the matter, Barclays let go of 15 Wall Street employees as part of a larger layoff of about 50 workers last month.
Barclays stock (NYSE: BCS) has increased by around 70% so far this year, while the S&P 500 has risen by 25% during the same time. In comparison, Bank of America (NYSE: BAC), a competitor of Barclays, has seen a 35% increase this year.
Emily Field, who leads European pharmaceutical research at Barclays, appears on 'Squawk Box' to talk about the current situation in the weight loss drug market. She also addresses the unsatisfactory trial results of Novo Nordisk's new weight loss drug, CagriSema, among other topics.
Emily Field, who leads European pharmaceutical research at Barclays, comments on the drop in Novo Nordisk's stock after their experimental obesity treatment, CagriSema, did not perform as hoped. She shares her insights on "Bloomberg Open Interest."
Naohiko Baba from Barclays shares his thoughts on the Bank of Japan's recent choice to keep interest rates unchanged. He believes that the central bank has the potential to increase rates twice in 2025.
Ajay Rajadhyaksha from Barclays believes that the Fed's lack of consistency has led to a negative response from the markets. He also suggests that the Fed might shift its approach again as soon as January, following the release of the December payroll data.
Investing in dividend stocks is a well-liked way to earn passive income. Unlike real estate, you don't need to manage dividend stocks as much.
Barclays Plc plans to raise annual bonuses by up to 20% in its investment banking division due to a better year for traders and advisory teams, as reported by sources close to the situation. This information comes from Bloomberg's William Shaw.
Jason Goldberg, a managing director and senior equity analyst at Barclays, appears on 'Money Movers' to talk about how the market reacted to the Federal Reserve's announcement. He also discusses whether higher interest rates are beneficial for banks and other related topics.
FAQ
- What is the primary business of Barclays?
- What is the ticker symbol for Barclays?
- Does Barclays pay dividends?
- What sector is Barclays in?
- What industry is Barclays in?
- What country is Barclays based in?
- When did Barclays go public?
- Is Barclays in the S&P 500?
- Is Barclays in the NASDAQ 100?
- Is Barclays in the Dow Jones?
- When was Barclays's last earnings report?
- When does Barclays report earnings?